MC
CASI

Moors & Cabot’s CASI Pharmaceuticals CASI Stock Holding History

Moors & Cabot’s Portfolio CASI Stock Details CASI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-2,294
Closed -$187K – 586
2018
Q2 		$187K Hold
2,294
– – 0.03% 519
2018
Q1 		$96K Sell
2,294
-172
-7% -$6.42K 0.01% 557
2017
Q4 		$82K Sell
2,466
-139
-5% -$3.78K 0.01% 549
2017
Q3 		$48K Hold
2,605
– – 0.01% 527
2017
Q2 		$27K Hold
2,605
– – ﹤0.01% 502
2017
Q1 		$38K Sell
2,605
-5,344
-67% -$72.6K 0.01% 502
2016
Q4 		$92K Sell
7,949
-466
-6% -$6.38K 0.02% 516
2016
Q3 		$93K Sell
8,415
-46
-0.5% -$505 0.02% 513
2016
Q2 		$102K Buy
8,461
+615
+8% +$7.76K 0.02% 488
2016
Q1 		$83K Buy
7,846
+1,398
+22% +$13.5K 0.02% 490
2015
Q4 		$59K Sell
6,448
-1,792
-22% -$20.3K 0.01% 481
2015
Q3 		$87K Sell
8,240
-576
-7% -$8.29K 0.02% 473
2015
Q2 		$162K Sell
8,816
-205
-2% -$3.06K 0.03% 475
2015
Q1 		$129K Sell
9,021
-879
-9% -$13.8K 0.02% 464
2014
Q4 		$132K Buy
9,900
+330
+3% +$5.17K 0.02% 467
2014
Q3 		$175K Buy
+9,570
New +$170K 0.03% 493
2014
Q2 		– Sell
-2,531
Closed -$46K – 536
2014
Q1 		$46K Buy
+2,531
New +$47.9K 0.01% 368

Other funds holding CASI

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
WSC
Wellington Shields & Co New York $446M AUM 38.92% 1-Year Est. Return
WSCM
Wellington Shields Capital Management New York $788M AUM 66.95% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $177B AUM 39.86% 1-Year Est. Return
AA
ALPS Advisors Denver, Colorado $21.3B AUM 23.41% 1-Year Est. Return

Moors & Cabot's CASI Position: Q3 2018 in Review

Moors & Cabot sold out of CASI Pharmaceuticals (CASI) in Q3 2018, closing a stake of 2,294 shares — an estimated $187K sold.

Moors & Cabot first reported a position in CASI in Q1 2014 and held it in 17 quarters. The position peaked at $187K in Q2 2018. 63 funds tracked by Wall St. Rank hold CASI as of Q3 2018.

  • Moors & Cabot reported no remaining CASI Pharmaceuticals position as of Q3 2018 after selling out during the quarter.
  • Moors & Cabot sold 2,294 CASI Pharmaceuticals shares in Q3 2018, an estimated $187K.
  • Moors & Cabot first reported a position in CASI Pharmaceuticals in Q1 2014 and held it in 17 quarters.
  • Moors & Cabot's CASI Pharmaceuticals position peaked at $187K in Q2 2018.
  • 63 funds tracked by Wall St. Rank held CASI Pharmaceuticals as of Q3 2018.

Based on Moors & Cabot's 13F filing for Q3 2018, filed 14 Nov 2018.